Skip to main content
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. — Investor Relations & Filings

Ticker · NERV ISIN · US6033802058 LEI · 54930017PANCHC5LYH79 US Manufacturing
Open in API
Filings indexed 589 across all filing types
Latest filing 2015-04-16 Director's Dealing
Country US United States of America
Listing US NERV

About Minerva Neurosciences, Inc.

https://www.minervaneurosciences.com/

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-04-16 English
FORM 4/A SUBMISSION
Director's Dealing
2015-04-16 English
Major Shareholding Notification 2015
Major Shareholding Notification
2015-04-10 English
Major Shareholding Notification 2015
Major Shareholding Notification
2015-04-09 English
10-K
Annual Report FY 2014
2015-03-26 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing financial results for the three and twelve months ended December 31, 2014, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 2915 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and states that a report or press release is furnished or attached, it should be classified as a Regulatory Filing (RNS) rather than an Annual Report (10-K) or Earnings Release (ER). Although the press release likely contains earnings information, the 8-K filing itself is an announcement of that release, not the release itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2015-03-26 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.